Point32Health and GRAIL Expand Galleri® Multi-Cancer Early Detection Blood Test Pilot to Harvard Pilgrim Health Care Members Insured in the Maine Health Insurance Marketplace

On December 15, 2022, Point32Health, the parent company of Harvard Pilgrim Health Care, and GRAIL, LLC, a health care company with a mission of detecting cancer early when it can be cured, announced the expansion of their pilot to offer GRAIL’s ground-breaking Galleri® multi-cancer early detection blood test to Harvard Pilgrim members at no cost who purchase their insurance on the Maine Health Insurance Marketplace. This expansion is the second phase of a pilot focused on collecting real-world evidence to assess the impact of the Galleri test on health care resource utilization and patient-reported outcomes.

Login Or Register To Read Full Story